You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
13 October 2026 - Racura Oncology Limited (ASX:RAC), a late clinical-stage biopharmaceutical company, announced on Monday that the Safety Review Committee (SRC) for the Phase 1 HARNESS-1 trial has approved its lead oncology drug, RC220, to proceed to...
13 October 2026 - Blue Lake Biotechnology Inc, a clinical-stage intranasal vaccine company, on Monday reported the presentation of interim data from the company's Phase 1/2a paediatric clinical trial of RSV vaccine candidate BLB201 as a late-bre...
13 October 2026 - Japanese electrical products manufacturer TWINBIRD Corporation (TOKYO:6897) on Tuesday announced the SC-UF25 Ultra-Low Temperature Portable Freezer, a compact 25-litre unit capable of reaching −86 degrees C, with commercial re...
13 October 2026 - Solvonis Therapeutics plc (LON:SVNS), a late clinical-stage biopharmaceutical company developing small-molecule therapeutics for central nervous system (CNS) disorders, said on Tuesday that it has signed a memorandum of understandin...
12 October 2026 - Taiwan and US-based biopharmaceutical company Foresee Pharmaceuticals Co., Ltd. (TPEX: 6576) said on Monday that its partner Changchun GeneScience Pharmaceutical Co., Ltd. (GenSci), part of Changchun High-Tech Industries (Group) Co....
12 October 2026 - ABL Texcell Diagnostics (Euronext Paris:ABLD), a provider of molecular biology tests, said on Monday that it has acquired IntegraGen's assets and business operations following a ruling by the Evry Commercial Court on 9 October ...
12 October 2026 - Danish biopharmaceutical company TETRAPHARM announced on Friday that it has appointed Rolf Sass Sorensen as its new chief executive officer.He succeeds Martin Rose, who founded the company along with Jesper Breum in 2018.This leader...